Sarah Milner, PhD is a director of Scientific Writing at PTC Therapeutics where she specializes in rare metabolic diseases. Day-to-day, she manages and writes clinical documents for pre-IND/IND/NDA submissions. Since entering the world of writing after completing her PhD in 2009, Sarah has always worked in the rare disease space, working on successful submissions ranging from gene therapy to small molecules. She has a background in Molecular Biology across several fields including Dermatology, Gene Therapy, and Metabolic Disease.
Linked in profile: https://www.linkedin.com/in/sarah-milner-969b9515/
Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.
Medical Writing is listed in the following indexes:
Gained in Translation
Getting Your Foot in the Door
Good Writing Practice
In the Bookstores
Medical Communications/Writing for Patients
My First Medical Writing
News from the EMA
Out on Our Own
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Lay out Designer